Xu Mei, Wang Chaokui, Tian Yuan, Kijlstra Aize, Yang Peizeng
Department of Opthalmology, The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Lab of Ophthalmology, Chongqing Eye Institute , Chongqing , P. R. China .
Ocul Immunol Inflamm. 2014 Aug;22(4):294-9. doi: 10.3109/09273948.2013.854391. Epub 2013 Dec 11.
Vogt-Koyanagi-Harada (VKH) syndrome is a multisystem disorder presumed to be mediated by an autoimmune response. Recent studies have shown that interleukin (IL) 25 was involved in the T-cell immune response. This study analyzed the expression and potential role of IL-25 in the pathogenesis of VKH syndrome.
The IL-25 serum levels were determined by enzyme-linked immunosorbent assay (ELISA). The IL-1β, IL-6, and TNF-α level in supernatants of PBMCs cultured with LPS in the absence or presence of recombinant(r) IL-25 was detected by ELISA.
A significantly decreased serum IL-25 level was found in VKH patients. In vitro experiments showed that rIL-25 was able to significantly inhibit the production of IL-1β, IL-6, and TNF-α by PBMCs from active VKH patients.
IL-25 may be involved in the development of VKH syndrome, possibly by inhibiting the expression of proinflammatory cytokines.
Vogt-小柳-原田(VKH)综合征是一种多系统疾病,推测由自身免疫反应介导。最近的研究表明,白细胞介素(IL)-25参与了T细胞免疫反应。本研究分析了IL-25在VKH综合征发病机制中的表达及潜在作用。
采用酶联免疫吸附测定(ELISA)法测定血清IL-25水平。用ELISA法检测在有无重组(r)IL-25情况下,脂多糖(LPS)刺激外周血单个核细胞(PBMCs)培养上清液中IL-1β、IL-6和肿瘤坏死因子-α(TNF-α)的水平。
VKH患者血清IL-25水平显著降低。体外实验表明,rIL-25能够显著抑制活动期VKH患者PBMCs产生IL-1β、IL-6和TNF-α。
IL-25可能参与VKH综合征的发病过程,可能是通过抑制促炎细胞因子的表达来实现的。